Since the emergence of SARS-CoV-2 in late 2019, companies throughout the scientific industry have been offering up their services for free to researchers working to overcome the pandemic. Synthace is the latest; the company is offering its Antha software “pro-bono” to any teams working on COVID-19 therapeutics discovery, diagnostics or production optimization.
The software enables flexible programming and control of lab automation; it can be deployed to accelerate the optimization of biologics production (through Design of Experiments), to optimize and automate assays (including qPCR) and to rapidly assemble DNA constructs.
Researchers are encouraged to get in contact with the company, whilst Synthace will also be directly reaching out to those they are aware are working on COVID-19 programs.
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.